Cefepime- Induced Non-Convulsive Status Epilepticus (NCSE)
Ahro Kim, Ji-Eun Kim, Young-Min Paek, Keun-Sik Hong, Young-Jin Cho, Joong-Yang Cho, Hee-Kyung Park, Hyeon-Kyoung Koo, Pamela Song
J Epilepsy Res. 2013;3(1):39-41.   Published online 2013 Jun 30     DOI: https://doi.org/10.14581/jer.13008
Citations to this article as recorded by Crossref logo
Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review
Samuel Deshayes, Antoine Coquerel, Renaud Verdon
Drug Safety.2017; 40(12): 1171.     CrossRef
Cefepime-induced neurotoxicity: a systematic review
Lauren E. Payne, David J. Gagnon, Richard R. Riker, David B. Seder, Elizabeth K. Glisic, Jane G. Morris, Gilles L. Fraser
Critical Care.2017;[Epub]     CrossRef
Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: Case report, pharmacokinetic modeling, and review of the literature
Laila-Yasmin Mani, Sébastien Kissling, Dragana Viceic, Bruno Vogt, Michel Burnier, Thierry Buclin, Delphine Renard
Hemodialysis International.2015; 19(2): 333.     CrossRef
Infraslow status epilepticus: A new form of subclinical status epilepticus recorded in a child with Sturge–Weber syndrome
Luis E. Bello-Espinosa
Epilepsy & Behavior.2015; 49: 193.     CrossRef